1
|
Filimonova MV, Soldatova OV, Shitova AA, Filimonov AS, Rybachuk VA, Kosachenko AO, Nikolaev KA, Demyashkin GA, Popov AA, Zelepukin IV, Kabashin AV, Deev SM, Kaprin AD, Shegay PV, Ivanov SA, Zavestovskaya IN, Koryakin SN. Bismuth Nanoparticles Increase Effectiveness of Proton Therapy of Ehrlich Carcinoma. Bull Exp Biol Med 2024; 176:626-630. [PMID: 38730109 DOI: 10.1007/s10517-024-06081-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2023] [Indexed: 05/12/2024]
Abstract
We studied the antitumor activity of the combined use of local proton irradiation in two modes (10 and 31 Gy) with preliminary intra-tumoral injection of two types of bismuth nanoparticles differing in surface coating: coated with the amphiphilic molecule Pluronic-F127 or Silane-PEG (5 kDa)-COOH polymer. Nanoparticles were used in doses of 0.75 and 1.5 mg/mouse. In two independent series on experimental tumor model (solid Ehrlich carcinoma), bismuth nanoparticles of both modifications injected directly into the tumor enhanced the antitumor effects of proton therapy. Moreover, the radiosensitizing effect of bismuth nanoparticles administered via this route increased with the increasing the doses of nanoparticles and the doses of radiation exposure. In our opinion, these promising data obtained for the first time extend the possibilities of treating malignant neoplasms.
Collapse
Affiliation(s)
- M V Filimonova
- A. Tsyb Medical Radiological Research Center - Branch of the National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, Obninsk, Russia.
- Obninsk Institute for Nuclear Power Engineering, National Research Nuclear University MEPhI, Obninsk, Russia.
| | - O V Soldatova
- A. Tsyb Medical Radiological Research Center - Branch of the National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, Obninsk, Russia
| | - A A Shitova
- A. Tsyb Medical Radiological Research Center - Branch of the National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, Obninsk, Russia
| | - A S Filimonov
- A. Tsyb Medical Radiological Research Center - Branch of the National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, Obninsk, Russia
| | - V A Rybachuk
- A. Tsyb Medical Radiological Research Center - Branch of the National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, Obninsk, Russia
| | - A O Kosachenko
- A. Tsyb Medical Radiological Research Center - Branch of the National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, Obninsk, Russia
| | - K A Nikolaev
- A. Tsyb Medical Radiological Research Center - Branch of the National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, Obninsk, Russia
| | - G A Demyashkin
- A. Tsyb Medical Radiological Research Center - Branch of the National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, Obninsk, Russia
| | - A A Popov
- National Research Nuclear University MEPhI, Moscow, Russia
| | - I V Zelepukin
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia
| | | | - S M Deev
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia
| | - A D Kaprin
- National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, Moscow, Russia
- Patrice Lumumba Peoples' Friendship University of Russia, (RUDN University), Moscow, Russia
| | - P V Shegay
- A. Tsyb Medical Radiological Research Center - Branch of the National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, Obninsk, Russia
- National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, Moscow, Russia
| | - S A Ivanov
- A. Tsyb Medical Radiological Research Center - Branch of the National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, Obninsk, Russia
- Obninsk Institute for Nuclear Power Engineering, National Research Nuclear University MEPhI, Obninsk, Russia
- Patrice Lumumba Peoples' Friendship University of Russia, (RUDN University), Moscow, Russia
| | - I N Zavestovskaya
- P. N. Lebedev Physical Institute, Russian Academy of Sciences, Moscow, Russia
| | - S N Koryakin
- A. Tsyb Medical Radiological Research Center - Branch of the National Medical Research Radiological Centre, Ministry of Health of the Russian Federation, Obninsk, Russia
- Obninsk Institute for Nuclear Power Engineering, National Research Nuclear University MEPhI, Obninsk, Russia
| |
Collapse
|
2
|
Shakhov PV, Tikhonowski GV, Popov AA, Iliasov AR, Petrunya DS, Lebedev AA, Klimentov SM, Zavestovskaya IN, Kabashin AV. Cytotoxicity of Laser-Synthesized Nanoparticles of Elemental Bismuth. Bull Exp Biol Med 2024; 176:501-504. [PMID: 38491259 DOI: 10.1007/s10517-024-06055-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2023] [Indexed: 03/18/2024]
Abstract
High X-ray absorption combined with photothermal properties make bismuth nanoparticles (Bi NP) a promising agent for multimodal cancer theranostics. However, the synthesis of Bi NP by the "classical" chemical methods has numerous limitations, including potential toxicity of the produced nanomaterials. Here we studied in vitro toxicity of laser-synthesized Bi NP coated with Pluronic F-127 on mouse fibroblast cell line L929. The survival of L929 cells decreased linearly with increasing the concentration of Bi NP in a concentration range of 3-500 μg/ml; the LC50 value was 57 μg/ml. The unique combination of functional properties and moderate toxicity of the laser-synthesized Bi NP makes them a new promising platform for sensitization of multimodal cancer theranostics.
Collapse
Affiliation(s)
- P V Shakhov
- National Research Nuclear University MEPhI, Moscow, Russia.
| | | | - A A Popov
- National Research Nuclear University MEPhI, Moscow, Russia
| | - A R Iliasov
- National Research Nuclear University MEPhI, Moscow, Russia
| | - D S Petrunya
- P. N. Lebedev Physical Institute, Russian Academy of Sciences, Moscow, Russia
| | - A A Lebedev
- National Research Nuclear University MEPhI, Moscow, Russia
| | - S M Klimentov
- National Research Nuclear University MEPhI, Moscow, Russia
| | - I N Zavestovskaya
- P. N. Lebedev Physical Institute, Russian Academy of Sciences, Moscow, Russia
| | - A V Kabashin
- LP3 Laboratory, Aix-Marseille University, CNRS, Marseille, France
| |
Collapse
|
3
|
Zavestovskaya IN, Kasatova AI, Kasatov DA, Babkova JS, Zelepukin IV, Kuzmina KS, Tikhonowski GV, Pastukhov AI, Aiyyzhy KO, Barmina EV, Popov AA, Razumov IA, Zavjalov EL, Grigoryeva MS, Klimentov SM, Ryabov VA, Deyev SM, Taskaev SY, Kabashin AV. Laser-Synthesized Elemental Boron Nanoparticles for Efficient Boron Neutron Capture Therapy. Int J Mol Sci 2023; 24:17088. [PMID: 38069412 PMCID: PMC10707216 DOI: 10.3390/ijms242317088] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2023] [Revised: 11/23/2023] [Accepted: 11/27/2023] [Indexed: 12/18/2023] Open
Abstract
Boron neutron capture therapy (BNCT) is one of the most appealing radiotherapy modalities, whose localization can be further improved by the employment of boron-containing nanoformulations, but the fabrication of biologically friendly, water-dispersible nanoparticles (NPs) with high boron content and favorable physicochemical characteristics still presents a great challenge. Here, we explore the use of elemental boron (B) NPs (BNPs) fabricated using the methods of pulsed laser ablation in liquids as sensitizers of BNCT. Depending on the conditions of laser-ablative synthesis, the used NPs were amorphous (a-BNPs) or partially crystallized (pc-BNPs) with a mean size of 20 nm or 50 nm, respectively. Both types of BNPs were functionalized with polyethylene glycol polymer to improve colloidal stability and biocompatibility. The NPs did not initiate any toxicity effects up to concentrations of 500 µg/mL, based on the results of MTT and clonogenic assay tests. The cells with BNPs incubated at a 10B concentration of 40 µg/mL were then irradiated with a thermal neutron beam for 30 min. We found that the presence of BNPs led to a radical enhancement in cancer cell death, namely a drop in colony forming capacity of SW-620 cells down to 12.6% and 1.6% for a-BNPs and pc-BNPs, respectively, while the relevant colony-forming capacity for U87 cells dropped down to 17%. The effect of cell irradiation by neutron beam uniquely was negligible under these conditions. Finally, to estimate the dose and regimes of irradiation for future BNCT in vivo tests, we studied the biodistribution of boron under intratumoral administration of BNPs in immunodeficient SCID mice and recorded excellent retention of boron in tumors. The obtained data unambiguously evidenced the effect of a neutron therapy enhancement, which can be attributed to efficient BNP-mediated generation of α-particles.
Collapse
Affiliation(s)
- Irina N. Zavestovskaya
- P. N. Lebedev Physical Institute of the Russian Academy of Sciences, Moscow 119991, Russia; (M.S.G.); (V.A.R.)
- Institute of Engineering Physics for Biomedicine (PhysBio), National Research Nuclear University MEPhI, Moscow 115409, Russia (I.V.Z.); (G.V.T.); (A.A.P.); (S.M.K.); (S.M.D.)
| | - Anna I. Kasatova
- Laboratory of BNCT, Budker Institute of Nuclear Physics of the Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia; (A.I.K.); (D.A.K.); (K.S.K.); (S.Y.T.)
| | - Dmitry A. Kasatov
- Laboratory of BNCT, Budker Institute of Nuclear Physics of the Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia; (A.I.K.); (D.A.K.); (K.S.K.); (S.Y.T.)
| | - Julia S. Babkova
- Institute of Engineering Physics for Biomedicine (PhysBio), National Research Nuclear University MEPhI, Moscow 115409, Russia (I.V.Z.); (G.V.T.); (A.A.P.); (S.M.K.); (S.M.D.)
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow 117997, Russia
| | - Ivan V. Zelepukin
- Institute of Engineering Physics for Biomedicine (PhysBio), National Research Nuclear University MEPhI, Moscow 115409, Russia (I.V.Z.); (G.V.T.); (A.A.P.); (S.M.K.); (S.M.D.)
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow 117997, Russia
| | - Ksenya S. Kuzmina
- Laboratory of BNCT, Budker Institute of Nuclear Physics of the Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia; (A.I.K.); (D.A.K.); (K.S.K.); (S.Y.T.)
| | - Gleb V. Tikhonowski
- Institute of Engineering Physics for Biomedicine (PhysBio), National Research Nuclear University MEPhI, Moscow 115409, Russia (I.V.Z.); (G.V.T.); (A.A.P.); (S.M.K.); (S.M.D.)
| | - Andrei I. Pastukhov
- LP3, Aix-Marseille University, CNRS, 13288 Marseille, France; (A.I.P.); (A.V.K.)
| | - Kuder O. Aiyyzhy
- A. M. Prokhorov General Physics Institute of the Russian Academy of Sciences, Moscow 119991, Russia; (K.O.A.); (E.V.B.)
| | - Ekaterina V. Barmina
- A. M. Prokhorov General Physics Institute of the Russian Academy of Sciences, Moscow 119991, Russia; (K.O.A.); (E.V.B.)
| | - Anton A. Popov
- Institute of Engineering Physics for Biomedicine (PhysBio), National Research Nuclear University MEPhI, Moscow 115409, Russia (I.V.Z.); (G.V.T.); (A.A.P.); (S.M.K.); (S.M.D.)
| | - Ivan A. Razumov
- Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia; (I.A.R.); (E.L.Z.)
| | - Evgenii L. Zavjalov
- Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia; (I.A.R.); (E.L.Z.)
| | - Maria S. Grigoryeva
- P. N. Lebedev Physical Institute of the Russian Academy of Sciences, Moscow 119991, Russia; (M.S.G.); (V.A.R.)
| | - Sergey M. Klimentov
- Institute of Engineering Physics for Biomedicine (PhysBio), National Research Nuclear University MEPhI, Moscow 115409, Russia (I.V.Z.); (G.V.T.); (A.A.P.); (S.M.K.); (S.M.D.)
| | - Vladimir A. Ryabov
- P. N. Lebedev Physical Institute of the Russian Academy of Sciences, Moscow 119991, Russia; (M.S.G.); (V.A.R.)
| | - Sergey M. Deyev
- Institute of Engineering Physics for Biomedicine (PhysBio), National Research Nuclear University MEPhI, Moscow 115409, Russia (I.V.Z.); (G.V.T.); (A.A.P.); (S.M.K.); (S.M.D.)
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow 117997, Russia
- Laboratory of Molecular Pharmacology, Institute of Molecular Theranostics, Sechenov First Moscow State Medical University (Sechenov University), Moscow 119991, Russia
- “Biomarker” Research Laboratory, Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan 420008, Russia
| | - Sergey Yu. Taskaev
- Laboratory of BNCT, Budker Institute of Nuclear Physics of the Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia; (A.I.K.); (D.A.K.); (K.S.K.); (S.Y.T.)
| | - Andrei V. Kabashin
- LP3, Aix-Marseille University, CNRS, 13288 Marseille, France; (A.I.P.); (A.V.K.)
| |
Collapse
|
4
|
Belyaev IB, Zelepukin IV, Tishchenko VK, Petriev VM, Trushina DB, Klimentov SM, Zavestovskaya IN, Ivanov SA, Kaprin AD, Deyev SM, Kabashin AV. Nanoparticles based on MIL-101 metal-organic frameworks as efficient carriers of therapeutic 188Re radionuclide for nuclear medicine. Nanotechnology 2023; 35:075103. [PMID: 37963406 DOI: 10.1088/1361-6528/ad0c74] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/28/2023] [Accepted: 11/14/2023] [Indexed: 11/16/2023]
Abstract
Nuclear medicine presents one of the most promising modalities for efficient non-invasive treatment of a variety of cancers, but the application of radionuclides in cancer therapy and diagnostics is severely limited by their nonspecific tissue accumulation and poor biocompatibility. Here, we explore the use of nanosized metal-organic frameworks (MOFs) as carriers of radionuclides to order to improve their delivery to tumour. To demonstrate the concept, we prepared polymer-coated MIL-101(Cr)-NH2MOFs and conjugated them with clinically utilized radionuclide188Re. The nanoparticles demonstrated high loading efficacy of radionuclide reaching specific activity of 49 MBq mg-1. Pharmacokinetics of loaded MOFs was investigated in mice bearing colon adenocarcinoma. The biological half-life of the radionuclide in blood was (20.9 ± 1.3) h, and nanoparticles enabled it to passively accumulate and retain in the tumour. The radionuclide delivery with MOFs led to a significant decrease of radioactivity uptake by the thyroid gland and stomach as compared with perrhenate salt injection, which is beneficial for reducing the side toxicity of nuclear therapy. The reported data on the functionalization and pharmacokinetics of MIL-101(Cr)-NH2for radionuclide delivery unveils the promising potential of these MOFs for nuclear medicine.
Collapse
Affiliation(s)
- Iaroslav B Belyaev
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), Institute for Physics and Engineering in Biomedicine (PhysBio), Moscow 115409, Russia
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, 117997 Moscow, Russia
| | - Ivan V Zelepukin
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), Institute for Physics and Engineering in Biomedicine (PhysBio), Moscow 115409, Russia
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, 117997 Moscow, Russia
| | - Victoria K Tishchenko
- A. Tsyb Medical Radiological Research Centre, Branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, 249036 Obninsk, Russia
| | - Vasiliy M Petriev
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), Institute for Physics and Engineering in Biomedicine (PhysBio), Moscow 115409, Russia
- A. Tsyb Medical Radiological Research Centre, Branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, 249036 Obninsk, Russia
| | - Daria B Trushina
- Federal Research Center 'Crystallography and Photonics', Russian Academy of Sciences, Moscow 119333, Russia
- Sechenov First Moscow State Medical University (Sechenov University), 119991, Moscow, Russia
| | - Sergey M Klimentov
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), Institute for Physics and Engineering in Biomedicine (PhysBio), Moscow 115409, Russia
| | - Irina N Zavestovskaya
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), Institute for Physics and Engineering in Biomedicine (PhysBio), Moscow 115409, Russia
| | - Sergey A Ivanov
- A. Tsyb Medical Radiological Research Centre, Branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, 249036 Obninsk, Russia
| | - Andrey D Kaprin
- A. Tsyb Medical Radiological Research Centre, Branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, 249036 Obninsk, Russia
| | - Sergey M Deyev
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), Institute for Physics and Engineering in Biomedicine (PhysBio), Moscow 115409, Russia
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, 117997 Moscow, Russia
- Sechenov First Moscow State Medical University (Sechenov University), 119991, Moscow, Russia
- Kazan Federal University, Institute of Fundamental Medicine and Biology, 420008, Kazan, Russia
| | - Andrei V Kabashin
- Aix Marseille University, CNRS, LP3, Campus de Luminy, Case 917, F-13288, Marseille, France
| |
Collapse
|
5
|
Grigoryeva MS, Kutlubulatova IA, Lukashenko SY, Fronya AA, Ivanov DS, Kanavin AP, Timoshenko VY, Zavestovskaya IN. Modeling of Short-Pulse Laser Interactions with Monolithic and Porous Silicon Targets with an Atomistic-Continuum Approach. Nanomaterials (Basel) 2023; 13:2809. [PMID: 37887962 PMCID: PMC10609206 DOI: 10.3390/nano13202809] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/13/2023] [Revised: 10/15/2023] [Accepted: 10/16/2023] [Indexed: 10/28/2023]
Abstract
The acquisition of reliable knowledge about the mechanism of short laser pulse interactions with semiconductor materials is an important step for high-tech technologies towards the development of new electronic devices, the functionalization of material surfaces with predesigned optical properties, and the manufacturing of nanorobots (such as nanoparticles) for bio-medical applications. The laser-induced nanostructuring of semiconductors, however, is a complex phenomenon with several interplaying processes occurring on a wide spatial and temporal scale. In this work, we apply the atomistic-continuum approach for modeling the interaction of an fs-laser pulse with a semiconductor target, using monolithic crystalline silicon (c-Si) and porous silicon (Si). This model addresses the kinetics of non-equilibrium laser-induced phase transitions with atomic resolution via molecular dynamics, whereas the effect of the laser-generated free carriers (electron-hole pairs) is accounted for via the dynamics of their density and temperature. The combined model was applied to study the microscopic mechanism of phase transitions during the laser-induced melting and ablation of monolithic crystalline (c-Si) and porous Si targets in a vacuum. The melting thresholds for the monolithic and porous targets were found to be 0.32 J/cm2 and 0.29 J/cm2, respectively. The limited heat conduction mechanism and the absence of internal stress accumulation were found to be involved in the processes responsible for the lowering of the melting threshold in the porous target. The results of this modeling were validated by comparing the melting thresholds obtained in the simulations to the experimental values. A difference in the mechanisms of ablation of the c-Si and porous Si targets was considered. Based on the simulation results, a prediction regarding the mechanism of the laser-assisted production of Si nanoparticles with the desired properties is drawn.
Collapse
Affiliation(s)
- Maria S. Grigoryeva
- Lebedev Physical Institute of the Russian Academy of Sciences, Leninskiy Prospect 53, 119991 Moscow, Russia; (M.S.G.); (I.A.K.); (S.Y.L.); (A.A.F.); (A.P.K.); (I.N.Z.)
| | - Irina A. Kutlubulatova
- Lebedev Physical Institute of the Russian Academy of Sciences, Leninskiy Prospect 53, 119991 Moscow, Russia; (M.S.G.); (I.A.K.); (S.Y.L.); (A.A.F.); (A.P.K.); (I.N.Z.)
- Institute of Engineering Physics for Biomedicine (PhysBio Institute), National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), Kashirskoe Shosse 31, 115409 Moscow, Russia
| | - Stanislav Yu. Lukashenko
- Lebedev Physical Institute of the Russian Academy of Sciences, Leninskiy Prospect 53, 119991 Moscow, Russia; (M.S.G.); (I.A.K.); (S.Y.L.); (A.A.F.); (A.P.K.); (I.N.Z.)
- Institute for Analytical Instrumentation of the Russian Academy of Sciences, Rizhsky Prospect, 26, 190103 St. Petersburg, Russia
| | - Anastasia A. Fronya
- Lebedev Physical Institute of the Russian Academy of Sciences, Leninskiy Prospect 53, 119991 Moscow, Russia; (M.S.G.); (I.A.K.); (S.Y.L.); (A.A.F.); (A.P.K.); (I.N.Z.)
- Institute of Engineering Physics for Biomedicine (PhysBio Institute), National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), Kashirskoe Shosse 31, 115409 Moscow, Russia
| | - Dmitry S. Ivanov
- Lebedev Physical Institute of the Russian Academy of Sciences, Leninskiy Prospect 53, 119991 Moscow, Russia; (M.S.G.); (I.A.K.); (S.Y.L.); (A.A.F.); (A.P.K.); (I.N.Z.)
| | - Andrey P. Kanavin
- Lebedev Physical Institute of the Russian Academy of Sciences, Leninskiy Prospect 53, 119991 Moscow, Russia; (M.S.G.); (I.A.K.); (S.Y.L.); (A.A.F.); (A.P.K.); (I.N.Z.)
| | - Victor Yu. Timoshenko
- Faculty of Physics, Lomonosov Moscow State University, Leninskie Gory, 1, 119991 Moscow, Russia;
| | - Irina N. Zavestovskaya
- Lebedev Physical Institute of the Russian Academy of Sciences, Leninskiy Prospect 53, 119991 Moscow, Russia; (M.S.G.); (I.A.K.); (S.Y.L.); (A.A.F.); (A.P.K.); (I.N.Z.)
- Institute of Engineering Physics for Biomedicine (PhysBio Institute), National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), Kashirskoe Shosse 31, 115409 Moscow, Russia
| |
Collapse
|
6
|
Zavestovskaya IN, Popov AL, Kolmanovich DD, Tikhonowski GV, Pastukhov AI, Savinov MS, Shakhov PV, Babkova JS, Popov AA, Zelepukin IV, Grigoryeva MS, Shemyakov AE, Klimentov SM, Ryabov VA, Prasad PN, Deyev SM, Kabashin AV. Boron Nanoparticle-Enhanced Proton Therapy for Cancer Treatment. Nanomaterials (Basel) 2023; 13:2167. [PMID: 37570485 PMCID: PMC10421420 DOI: 10.3390/nano13152167] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/16/2023] [Revised: 07/20/2023] [Accepted: 07/21/2023] [Indexed: 08/13/2023]
Abstract
Proton therapy is one of the promising radiotherapy modalities for the treatment of deep-seated and unresectable tumors, and its efficiency can further be enhanced by using boron-containing substances. Here, we explore the use of elemental boron (B) nanoparticles (NPs) as sensitizers for proton therapy enhancement. Prepared by methods of pulsed laser ablation in water, the used B NPs had a mean size of 50 nm, while a subsequent functionalization of the NPs by polyethylene glycol improved their colloidal stability in buffers. Laser-synthesized B NPs were efficiently absorbed by MNNG/Hos human osteosarcoma cells and did not demonstrate any remarkable toxicity effects up to concentrations of 100 ppm, as followed from the results of the MTT and clonogenic assay tests. Then, we assessed the efficiency of B NPs as sensitizers of cancer cell death under irradiation by a 160.5 MeV proton beam. The irradiation of MNNG/Hos cells at a dose of 3 Gy in the presence of 80 and 100 ppm of B NPs led to a 2- and 2.7-fold decrease in the number of formed cell colonies compared to control samples irradiated in the absence of NPs. The obtained data unambiguously evidenced the effect of a strong proton therapy enhancement mediated by B NPs. We also found that the proton beam irradiation of B NPs leads to the generation of reactive oxygen species (ROS), which evidences a possible involvement of the non-nuclear mechanism of cancer cell death related to oxidative stress. Offering a series of advantages, including a passive targeting option and the possibility of additional theranostic functionalities based on the intrinsic properties of B NPs (e.g., photothermal therapy or neutron boron capture therapy), the proposed concept promises a major advancement in proton beam-based cancer treatment.
Collapse
Affiliation(s)
- Irina N. Zavestovskaya
- P. N. Lebedev Physical Institute of the Russian Academy of Sciences, Leninsky Prospect 53, 119991 Moscow, Russia; (A.L.P.); (D.D.K.); (M.S.G.); (A.E.S.); (V.A.R.)
- Bionanophotonics Laboratory, Institute of Engineering Physics for Biomedicine (PhysBio), National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), Kashirskoe Shosse 31, 115409 Moscow, Russia; (G.V.T.); (M.S.S.); (P.V.S.); (J.S.B.); (A.A.P.); (S.M.K.); (P.N.P.); (S.M.D.)
| | - Anton L. Popov
- P. N. Lebedev Physical Institute of the Russian Academy of Sciences, Leninsky Prospect 53, 119991 Moscow, Russia; (A.L.P.); (D.D.K.); (M.S.G.); (A.E.S.); (V.A.R.)
- Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, 3 Institutskaya St., 142290 Pushchino, Russia
| | - Danil D. Kolmanovich
- P. N. Lebedev Physical Institute of the Russian Academy of Sciences, Leninsky Prospect 53, 119991 Moscow, Russia; (A.L.P.); (D.D.K.); (M.S.G.); (A.E.S.); (V.A.R.)
- Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, 3 Institutskaya St., 142290 Pushchino, Russia
| | - Gleb V. Tikhonowski
- Bionanophotonics Laboratory, Institute of Engineering Physics for Biomedicine (PhysBio), National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), Kashirskoe Shosse 31, 115409 Moscow, Russia; (G.V.T.); (M.S.S.); (P.V.S.); (J.S.B.); (A.A.P.); (S.M.K.); (P.N.P.); (S.M.D.)
| | | | - Maxim S. Savinov
- Bionanophotonics Laboratory, Institute of Engineering Physics for Biomedicine (PhysBio), National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), Kashirskoe Shosse 31, 115409 Moscow, Russia; (G.V.T.); (M.S.S.); (P.V.S.); (J.S.B.); (A.A.P.); (S.M.K.); (P.N.P.); (S.M.D.)
| | - Pavel V. Shakhov
- Bionanophotonics Laboratory, Institute of Engineering Physics for Biomedicine (PhysBio), National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), Kashirskoe Shosse 31, 115409 Moscow, Russia; (G.V.T.); (M.S.S.); (P.V.S.); (J.S.B.); (A.A.P.); (S.M.K.); (P.N.P.); (S.M.D.)
| | - Julia S. Babkova
- Bionanophotonics Laboratory, Institute of Engineering Physics for Biomedicine (PhysBio), National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), Kashirskoe Shosse 31, 115409 Moscow, Russia; (G.V.T.); (M.S.S.); (P.V.S.); (J.S.B.); (A.A.P.); (S.M.K.); (P.N.P.); (S.M.D.)
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia;
| | - Anton A. Popov
- Bionanophotonics Laboratory, Institute of Engineering Physics for Biomedicine (PhysBio), National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), Kashirskoe Shosse 31, 115409 Moscow, Russia; (G.V.T.); (M.S.S.); (P.V.S.); (J.S.B.); (A.A.P.); (S.M.K.); (P.N.P.); (S.M.D.)
| | - Ivan V. Zelepukin
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia;
| | - Maria S. Grigoryeva
- P. N. Lebedev Physical Institute of the Russian Academy of Sciences, Leninsky Prospect 53, 119991 Moscow, Russia; (A.L.P.); (D.D.K.); (M.S.G.); (A.E.S.); (V.A.R.)
| | - Alexander E. Shemyakov
- P. N. Lebedev Physical Institute of the Russian Academy of Sciences, Leninsky Prospect 53, 119991 Moscow, Russia; (A.L.P.); (D.D.K.); (M.S.G.); (A.E.S.); (V.A.R.)
| | - Sergey M. Klimentov
- Bionanophotonics Laboratory, Institute of Engineering Physics for Biomedicine (PhysBio), National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), Kashirskoe Shosse 31, 115409 Moscow, Russia; (G.V.T.); (M.S.S.); (P.V.S.); (J.S.B.); (A.A.P.); (S.M.K.); (P.N.P.); (S.M.D.)
| | - Vladimir A. Ryabov
- P. N. Lebedev Physical Institute of the Russian Academy of Sciences, Leninsky Prospect 53, 119991 Moscow, Russia; (A.L.P.); (D.D.K.); (M.S.G.); (A.E.S.); (V.A.R.)
| | - Paras N. Prasad
- Bionanophotonics Laboratory, Institute of Engineering Physics for Biomedicine (PhysBio), National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), Kashirskoe Shosse 31, 115409 Moscow, Russia; (G.V.T.); (M.S.S.); (P.V.S.); (J.S.B.); (A.A.P.); (S.M.K.); (P.N.P.); (S.M.D.)
- Department of Chemistry, Institute for Lasers, Photonics, and Biophotonics, The State University of New York at Buffalo, Buffalo, NY 14260, USA
| | - Sergey M. Deyev
- Bionanophotonics Laboratory, Institute of Engineering Physics for Biomedicine (PhysBio), National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), Kashirskoe Shosse 31, 115409 Moscow, Russia; (G.V.T.); (M.S.S.); (P.V.S.); (J.S.B.); (A.A.P.); (S.M.K.); (P.N.P.); (S.M.D.)
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 117997 Moscow, Russia;
- “Biomarker” Research Laboratory, Institute of Fundamental Medicine and Biology, Kazan Federal University, 18 Kremlyovskaya St., 420008 Kazan, Russia
- Institute of Molecular Theranostics, Sechenov First Moscow State Medical University, 119991 Moscow, Russia
| | | |
Collapse
|
7
|
Pastukhov AI, Belyaev IB, Bulmahn JC, Zelepukin IV, Popov AA, Zavestovskaya IN, Klimentov SM, Deyev SM, Prasad PN, Kabashin AV. Laser-ablative aqueous synthesis and characterization of elemental boron nanoparticles for biomedical applications. Sci Rep 2022; 12:9129. [PMID: 35650237 PMCID: PMC9159993 DOI: 10.1038/s41598-022-13066-8] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2021] [Accepted: 05/12/2022] [Indexed: 11/26/2022] Open
Abstract
Boron-based nano-formulations look very promising for biomedical applications, including photo- and boron neutron capture therapies, but the fabrication of non-toxic water-dispersible boron nanoparticles (NPs), which contain the highest boron atom concentration, is difficult using currently available chemical and plasma synthesis methods. Here, we demonstrate purely aqueous synthesis of clean boron NPs by methods of femtosecond laser ablation from a solid boron target in water, thus free of any toxic organic solvents, and characterize their properties. We show that despite highly oxidizing water ambience, the laser-ablative synthesis process follows an unusual scenario leading to the formation of boron NPs together with boric acid (H3BO3) as an oxidation by-product coating the nanoparticles, which acts to stabilize the elemental boron NPs dispersion. We then demonstrate the purification of boron NPs from residual boric acid in deionized water, followed by their coating with polyethylene glycol to improve colloidal stability and biocompatibility. It was found that the formed NPs have a spherical shape with averaged size of about 37 nm, and are composed of elemental boron in mostly amorphous phase with the presence of certain crystalline fraction. The synthesized NPs demonstrate low toxicity and exhibit strong absorption in the NIR window of relative tissue transparency, promising their use in photoacoustic imaging and phototherapy, in addition to their promise for neutron capture therapy. This combined potential ability of generating imaging and therapy functionalities makes laser-synthesized B NPs a very promising multifunctional agent for biomedical applications.
Collapse
Affiliation(s)
- Andrei I Pastukhov
- LP3, CNRS, Aix Marseille University, Campus de Luminy, Case 917, 13288, Marseille, France
| | - Iaroslav B Belyaev
- Institute of Engineering Physics for Biomedicine (PhysBio), MEPHI, Moscow, Russia, 115409.,Russian Academy of Sciences, 16/10 Miklukho-Maklaya St, Moscow, Russia, 117997
| | - Julia C Bulmahn
- Department of Chemistry, The Institute for Lasers, Photonics, and Biophotonics, University at Buffalo, The State University of New York, Buffalo, NY, 14260, USA
| | - Ivan V Zelepukin
- Institute of Engineering Physics for Biomedicine (PhysBio), MEPHI, Moscow, Russia, 115409.,Russian Academy of Sciences, 16/10 Miklukho-Maklaya St, Moscow, Russia, 117997
| | - Anton A Popov
- Institute of Engineering Physics for Biomedicine (PhysBio), MEPHI, Moscow, Russia, 115409
| | - Irina N Zavestovskaya
- Institute of Engineering Physics for Biomedicine (PhysBio), MEPHI, Moscow, Russia, 115409.,P. N. Lebedev Physical Institute of the Russian Academy of Science, Leninskiy Pr. 53, Moscow, Russia, 119991
| | - Sergei M Klimentov
- Institute of Engineering Physics for Biomedicine (PhysBio), MEPHI, Moscow, Russia, 115409
| | - Sergey M Deyev
- Institute of Engineering Physics for Biomedicine (PhysBio), MEPHI, Moscow, Russia, 115409.,Russian Academy of Sciences, 16/10 Miklukho-Maklaya St, Moscow, Russia, 117997
| | - Paras N Prasad
- Institute of Engineering Physics for Biomedicine (PhysBio), MEPHI, Moscow, Russia, 115409. .,Department of Chemistry, The Institute for Lasers, Photonics, and Biophotonics, University at Buffalo, The State University of New York, Buffalo, NY, 14260, USA.
| | - Andrei V Kabashin
- LP3, CNRS, Aix Marseille University, Campus de Luminy, Case 917, 13288, Marseille, France.
| |
Collapse
|
8
|
Abstract
Nuclear medicine is expected to make major advances in cancer diagnosis and therapy; tumor-targeted radiopharmaceuticals preferentially eradicate tumors while causing minimal damage to healthy tissues. The current scope of nuclear medicine can be significantly expanded by integration with nanomedicine, which utilizes nanoparticles for cancer diagnosis and therapy by capitalizing on the increased surface area-to-volume ratio, the passive/active targeting ability and high loading capacity, the greater interaction cross section with biological tissues, the rich surface properties of nanomaterials, the facile decoration of nanomaterials with a plethora of functionalities, and the potential for multiplexing several functionalities within one construct. This review provides a comprehensive discussion of nuclear nanomedicine using tumor-targeted nanoparticles for cancer radiation therapy with either pre-embedded radionuclides or nonradioactive materials which can be extrinsically triggered using various external nuclear particle sources to produce in situ radioactivity. In addition, it describes the prospect of combining nuclear nanomedicine with other modalities to enable synergistically enhanced combination therapies. The review also discusses advances in the fabrication of radionuclides as well as describes laser ablation technologies for producing nanoradiopharmaceuticals, which combine the ease of production with exceptional purity and rapid biodegradability, along with additional imaging or therapeutic functionalities. From a practical standpoint, these attributes of nanoradiopharmaceuticals may provide distinct advantages in diagnostic/therapeutic sensitivity and specificity, imaging resolution, and scalability of turnkey platforms. Coupling image-guided targeted radiation therapy with the possibility of in situ activation of nanomaterials as well as combining with other therapeutic modalities using a multifunctional nanoplatform could herald an era of exciting technological and therapeutic advances to radically transform the landscape of nuclear medicine. The review concludes with a discussion of current challenges and presents the authors' views on future opportunities to stimulate further research in this rewarding field of high societal impact.
Collapse
Affiliation(s)
- Indrajit Roy
- Department of Chemistry, University of Delhi, Delhi 110007, India
| | - Sunil Krishnan
- Department of Radiation Oncology, Mayo Clinic Florida, Jacksonville, Florida 32224, United States
| | - Andrei V Kabashin
- Aix Marseille University, CNRS, LP3, Campus de Luminy - Case 917, 13288 Marseille, France
- MEPhI, Institute of Engineering Physics for Biomedicine (PhysBio), 115409 Moscow, Russia
| | - Irina N Zavestovskaya
- MEPhI, Institute of Engineering Physics for Biomedicine (PhysBio), 115409 Moscow, Russia
- Nuclear Physics and Astrophysics Department, LPI of RAS, 119991 Moscow, Russia
| | - Paras N Prasad
- MEPhI, Institute of Engineering Physics for Biomedicine (PhysBio), 115409 Moscow, Russia
- Department of Chemistry and Institute for Lasers, Photonics, and Biophotonics, University at Buffalo, The State University of New York, Buffalo, New York 14260, United States
| |
Collapse
|
9
|
Tishchenko VK, Petriev VM, Mikhailovskaya AA, Stepchenkova ED, Timoshenko VY, Postnov AA, Zavestovskaya IN. Experimental Study of the Biodistribution of New Bone-Seeking Compounds Based on Phosphonic Acids and Gallium-68. Bull Exp Biol Med 2020; 168:777-780. [PMID: 32333308 DOI: 10.1007/s10517-020-04800-1] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2019] [Indexed: 11/29/2022]
Abstract
We investigate biodistribution of gallium-labeled hydroxyethylidenediphosphonic acid (68Ga-HEDP) and diethylenetriaminepentakis(methylenephosphonic acid) (68Ga-DTPMP) in intact Wistar rats. It was shown that 68Ga-DTPMP accumulated mainly in the bone tissue providing high femur/blood and femur/muscle ratios and had high stability in vivo. In contrast, 68Ga-HEDP was characterized by low stability and high uptake of radioactivity in blood throughout the study. So 68Ga-DTPMP can be considered as a new prospective radiotracer in oncology for imaging bone tissue metastasis by positron emission tomography.
Collapse
Affiliation(s)
- V K Tishchenko
- National Medical Research Centre of Radiology, Ministry of Health of the Russian Federation, Obninsk, Russia
| | - V M Petriev
- National Medical Research Centre of Radiology, Ministry of Health of the Russian Federation, Obninsk, Russia. .,National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), Moscow, Russia.
| | - A A Mikhailovskaya
- National Medical Research Centre of Radiology, Ministry of Health of the Russian Federation, Obninsk, Russia
| | - E D Stepchenkova
- National Medical Research Centre of Radiology, Ministry of Health of the Russian Federation, Obninsk, Russia
| | - V Yu Timoshenko
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), Moscow, Russia.,P. N. Lebedev Physical Institute, Russian Academy of Sciences, Moscow, Russia.,Faculty of Physics, M. V. Lomonosov Moscow State University, Moscow, Russia
| | - A A Postnov
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), Moscow, Russia
| | - I N Zavestovskaya
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), Moscow, Russia.,P. N. Lebedev Physical Institute, Russian Academy of Sciences, Moscow, Russia
| |
Collapse
|
10
|
Ivanov DS, Izgin T, Maiorov AN, Veiko VP, Rethfeld B, Dombrovska YI, Garcia ME, Zavestovskaya IN, Klimentov SM, Kabashin AV. Numerical Investigation of Ultrashort Laser-Ablative Synthesis of Metal Nanoparticles in Liquids Using the Atomistic-Continuum Model. Molecules 2019; 25:molecules25010067. [PMID: 31878215 PMCID: PMC6982913 DOI: 10.3390/molecules25010067] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2019] [Revised: 12/16/2019] [Accepted: 12/17/2019] [Indexed: 12/20/2022] Open
Abstract
We present a framework based on the atomistic continuum model, combining the Molecular Dynamics (MD) and Two Temperature Model (TTM) approaches, to characterize the growth of metal nanoparticles (NPs) under ultrashort laser ablation from a solid target in water ambient. The model is capable of addressing the kinetics of fast non-equilibrium laser-induced phase transition processes at atomic resolution, while in continuum it accounts for the effect of free carriers, playing a determinant role during short laser pulse interaction processes with metals. The results of our simulations clarify possible mechanisms, which can be responsible for the observed experimental data, including the presence of two populations of NPs, having a small (5–15 nm) and larger (tens of nm) mean size. The formed NPs are of importance for a variety of applications in energy, catalysis and healthcare.
Collapse
Affiliation(s)
- Dmitry S. Ivanov
- Department of Physics and OPTIMAS Research Center, TU Kaiserslautern, 67663 Kaiserslautern, Germany;
- Institute of Physics and Center for Interdisciplinary Nanostructure Science and Technology (CINSaT), University of Kassel, 34125 Kassel, Germany; (T.I.); (M.E.G.)
- Institute of Engineering Physics for Biomedicine (PhysBio), MEPHI, 115409 Moscow, Russia; (A.N.M.); (Y.I.D.); (I.N.Z.); (S.M.K.)
- Physics Department, ITMO University, 197101 St. Petersburg, Russia;
- Correspondence: (D.S.I.); (A.V.K.)
| | - Thomas Izgin
- Institute of Physics and Center for Interdisciplinary Nanostructure Science and Technology (CINSaT), University of Kassel, 34125 Kassel, Germany; (T.I.); (M.E.G.)
| | - Alexey N. Maiorov
- Institute of Engineering Physics for Biomedicine (PhysBio), MEPHI, 115409 Moscow, Russia; (A.N.M.); (Y.I.D.); (I.N.Z.); (S.M.K.)
| | - Vadim P. Veiko
- Physics Department, ITMO University, 197101 St. Petersburg, Russia;
| | - Baerbel Rethfeld
- Department of Physics and OPTIMAS Research Center, TU Kaiserslautern, 67663 Kaiserslautern, Germany;
| | - Yaroslava I. Dombrovska
- Institute of Engineering Physics for Biomedicine (PhysBio), MEPHI, 115409 Moscow, Russia; (A.N.M.); (Y.I.D.); (I.N.Z.); (S.M.K.)
| | - Martin E. Garcia
- Institute of Physics and Center for Interdisciplinary Nanostructure Science and Technology (CINSaT), University of Kassel, 34125 Kassel, Germany; (T.I.); (M.E.G.)
| | - Irina N. Zavestovskaya
- Institute of Engineering Physics for Biomedicine (PhysBio), MEPHI, 115409 Moscow, Russia; (A.N.M.); (Y.I.D.); (I.N.Z.); (S.M.K.)
- P. N. Lebedev Physical Institute of Russian Acad. Sci., Leninskiy Pr. 53, 119991 Moscow, Russia
| | - Sergey M. Klimentov
- Institute of Engineering Physics for Biomedicine (PhysBio), MEPHI, 115409 Moscow, Russia; (A.N.M.); (Y.I.D.); (I.N.Z.); (S.M.K.)
| | - Andrei V. Kabashin
- Department of Physics and OPTIMAS Research Center, TU Kaiserslautern, 67663 Kaiserslautern, Germany;
- LP3, Aix Marseille Univ, CNRS, LP3, Campus de Luminy, Case 917, 13288 Marseille, France
- Correspondence: (D.S.I.); (A.V.K.)
| |
Collapse
|
11
|
Kabashin AV, Singh A, Swihart MT, Zavestovskaya IN, Prasad PN. Laser-Processed Nanosilicon: A Multifunctional Nanomaterial for Energy and Healthcare. ACS Nano 2019; 13:9841-9867. [PMID: 31490658 DOI: 10.1021/acsnano.9b04610] [Citation(s) in RCA: 38] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
This review describes promising laser-based approaches to produce silicon nanostructures, including laser ablation of solid Si targets in residual gases and liquids and laser pyrolysis of silane. These methods are different from, and complementary to, widely used porous silicon technology and alternative synthesis routes. One can use these methods to make stable colloidal dispersions of silicon nanoparticles in both organic and aqueous media, which are suitable for a multitude of applications across the important fields of energy and healthcare. Size tailoring allows production of Si quantum dots with efficient photoluminescence that can be tuned across a broad spectral range from the visible to near-IR by varying particle size and surface functionalization. These nanoparticles can also be integrated with other nanomaterials to make multifunctional composites incorporating magnetic and/or plasmonic components. In the energy domain, this review highlights applications to photovoltaics and photodetectors, nanostructured silicon anodes for lithium ion batteries, and hydrogen generation from water. Application to nanobiophotonics and nanomedicine profits from the excellent biocompatibility and biodegradability of nanosilicon. These applications encompass several types of bioimaging and various therapies, including photodynamic therapy, RF thermal therapy, and radiotherapy. The review concludes with a discussion of challenges and opportunities in the applications of laser-processed nanosilicon.
Collapse
Affiliation(s)
- Andrei V Kabashin
- Aix-Marseille Univ , CNRS, LP3, Marseille 13288 , France
- MEPhI, Institute of Engineering Physics for Biomedicine (PhysBio) , 31 Kashirskoe sh. , 115409 Moscow , Russia
| | - Ajay Singh
- Institute for Lasers, Photonics, and Biophotonics , University at Buffalo, The State University of New York , Buffalo , New York 14260-3000 , United States
| | - Mark T Swihart
- Institute for Lasers, Photonics, and Biophotonics , University at Buffalo, The State University of New York , Buffalo , New York 14260-3000 , United States
- Department of Chemical and Biological Engineering and RENEW Institute , University at Buffalo, The State University of New York , Buffalo , New York 14260-4200 , United States
| | - Irina N Zavestovskaya
- MEPhI, Institute of Engineering Physics for Biomedicine (PhysBio) , 31 Kashirskoe sh. , 115409 Moscow , Russia
| | - Paras N Prasad
- MEPhI, Institute of Engineering Physics for Biomedicine (PhysBio) , 31 Kashirskoe sh. , 115409 Moscow , Russia
- Institute for Lasers, Photonics, and Biophotonics , University at Buffalo, The State University of New York , Buffalo , New York 14260-3000 , United States
| |
Collapse
|
12
|
Zhang K, Ivanov DS, Ganeev RA, Boltaev GS, Krishnendu PS, Singh SC, Garcia ME, Zavestovskaya IN, Guo C. Pulse Duration and Wavelength Effects of Laser Ablation on the Oxidation, Hydrolysis, and Aging of Aluminum Nanoparticles in Water. Nanomaterials (Basel) 2019; 9:nano9050767. [PMID: 31109104 PMCID: PMC6566421 DOI: 10.3390/nano9050767] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/27/2019] [Revised: 05/14/2019] [Accepted: 05/14/2019] [Indexed: 11/24/2022]
Abstract
We analyzed the formation of the aluminum (Al) nanoparticles (NPs) with triangular shape obtained by ablating Al bulk in liquid using pulses with different durations (5 ns, 200 ps, and 30 fs) and wavelengths (355 nm, 800 nm, and 1064 nm). We report three stages of synthesis and aging of Al NPs: Formation, transformation, and stable stage. The NPs prepared by different pulses are almost identical at the initial stage. The effects of duration and wavelength of the ablation pulses on the aging of NPs are revealed. Pulse duration is determined to be essential for morphological transformation of NPs, while pulse wavelength strongly influences particle sizes. NPs produced by ultra-short pulses have smaller sizes and narrow size distribution. We demonstrate that oxidation and hydrolysis of Al in water are the results of ablation for all pulse durations and wavelengths, which also strongly modify the preferable reaction path of NPs in water, thus affecting the composition and morphology of triangle NPs. The results of modeling of the NPs generation in water due to a 50 ps laser pulse interacting with a thick Al target are presented. Water-based effects in the formation of NPs, their evolution, and solidification are considered from the mechanical and thermophysical points of view. The detailed analysis of the modeling results allowed for determination of the main mechanism responsible for the ablation process followed by the NPs formation.
Collapse
Affiliation(s)
- Ke Zhang
- The Guo China-US Photonics Laboratory, State Key Laboratory of Applied Optics, Changchun Institute of Optics, Fine Mechanics, and Physics, Chinese Academy of Sciences, Changchun 130033, China.
- University of Chinese Academy of Sciences, Beijing 100049, China.
| | - Dmitry S Ivanov
- Theoretical Physics Department, University of Kassel, 34132 Kassel, Germany.
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), 115409 Moscow, Russia.
| | - Rashid A Ganeev
- The Guo China-US Photonics Laboratory, State Key Laboratory of Applied Optics, Changchun Institute of Optics, Fine Mechanics, and Physics, Chinese Academy of Sciences, Changchun 130033, China.
| | - Ganjaboy S Boltaev
- The Guo China-US Photonics Laboratory, State Key Laboratory of Applied Optics, Changchun Institute of Optics, Fine Mechanics, and Physics, Chinese Academy of Sciences, Changchun 130033, China.
| | - Pandiyalackal S Krishnendu
- The Guo China-US Photonics Laboratory, State Key Laboratory of Applied Optics, Changchun Institute of Optics, Fine Mechanics, and Physics, Chinese Academy of Sciences, Changchun 130033, China.
| | - Subhash C Singh
- The Guo China-US Photonics Laboratory, State Key Laboratory of Applied Optics, Changchun Institute of Optics, Fine Mechanics, and Physics, Chinese Academy of Sciences, Changchun 130033, China.
- The Institute of Optics, University of Rochester, Rochester, NY 14627, USA.
| | - Martin E Garcia
- Theoretical Physics Department, University of Kassel, 34132 Kassel, Germany.
| | - Irina N Zavestovskaya
- National Research Nuclear University MEPhI (Moscow Engineering Physics Institute), 115409 Moscow, Russia.
| | - Chunlei Guo
- The Guo China-US Photonics Laboratory, State Key Laboratory of Applied Optics, Changchun Institute of Optics, Fine Mechanics, and Physics, Chinese Academy of Sciences, Changchun 130033, China.
- The Institute of Optics, University of Rochester, Rochester, NY 14627, USA.
| |
Collapse
|
13
|
Petriev VM, Tischenko VK, Mikhailovskaya AA, Popov AA, Tselikov G, Zelepukin I, Deyev SM, Kaprin AD, Ivanov S, Timoshenko VY, Prasad PN, Zavestovskaya IN, Kabashin AV. Nuclear nanomedicine using Si nanoparticles as safe and effective carriers of 188Re radionuclide for cancer therapy. Sci Rep 2019; 9:2017. [PMID: 30765778 PMCID: PMC6376125 DOI: 10.1038/s41598-018-38474-7] [Citation(s) in RCA: 42] [Impact Index Per Article: 8.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2018] [Accepted: 11/19/2018] [Indexed: 11/25/2022] Open
Abstract
Nuclear nanomedicine, with its targeting ability and heavily loading capacity, along with its enhanced retention to avoid rapid clearance as faced with molecular radiopharmaceuticals, provides unique opportunities to treat tumors and metastasis. Despite these promises, this field has seen limited activities, primarily because of a lack of suitable nanocarriers, which are safe, excretable and have favorable pharmacokinetics to efficiently deliver and retain radionuclides in a tumor. Here, we introduce biodegradable laser-synthesized Si nanoparticles having round shape, controllable low-dispersion size, and being free of any toxic impurities, as highly suitable carriers of therapeutic 188Re radionuclide. The conjugation of the polyethylene glycol-coated Si nanoparticles with radioactive 188Re takes merely 1 hour, compared to its half-life of 17 hours. When intravenously administered in a Wistar rat model, the conjugates demonstrate free circulation in the blood stream to reach all organs and target tumors, which is radically in contrast with that of the 188Re salt that mostly accumulates in the thyroid gland. We also show that the nanoparticles ensure excellent retention of 188Re in tumor, not possible with the salt, which enables one to maximize the therapeutic effect, as well as exhibit a complete time-delayed conjugate bioelimination. Finally, our tests on rat survival demonstrate excellent therapeutic effect (72% survival compared to 0% of the control group). Combined with a series of imaging and therapeutic functionalities based on unique intrinsic properties of Si nanoparticles, the proposed biodegradable complex promises a major advancement in nuclear nanomedicine.
Collapse
Affiliation(s)
- V M Petriev
- MEPhI, Institute of Engineering Physics for Biomedicine (PhysBio), 115409, Moscow, Russia
- National Medical Research Radiological Center of the Ministry of Health of the Russian Federation, Obninsk, Russia
| | - V K Tischenko
- National Medical Research Radiological Center of the Ministry of Health of the Russian Federation, Obninsk, Russia
| | - A A Mikhailovskaya
- National Medical Research Radiological Center of the Ministry of Health of the Russian Federation, Obninsk, Russia
| | - A A Popov
- Aix Marseille Univ, CNRS, LP3, Campus de Luminy - Case 917, 13288, Marseille, France
| | - G Tselikov
- Aix Marseille Univ, CNRS, LP3, Campus de Luminy - Case 917, 13288, Marseille, France
| | - I Zelepukin
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 16/10 Miklukho-Maklaya St, Moscow, 117997, Russia
| | - S M Deyev
- MEPhI, Institute of Engineering Physics for Biomedicine (PhysBio), 115409, Moscow, Russia
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 16/10 Miklukho-Maklaya St, Moscow, 117997, Russia
- National Research Tomsk Polytechnic University, Tomsk, Russia
| | - A D Kaprin
- National Medical Research Radiological Center of the Ministry of Health of the Russian Federation, Obninsk, Russia
| | - S Ivanov
- National Medical Research Radiological Center of the Ministry of Health of the Russian Federation, Obninsk, Russia
| | - V Yu Timoshenko
- MEPhI, Institute of Engineering Physics for Biomedicine (PhysBio), 115409, Moscow, Russia
- Lomonosov Moscow State University, Physics Department, Leninskie Gory 1, 119991, Moscow, Russia
| | - P N Prasad
- MEPhI, Institute of Engineering Physics for Biomedicine (PhysBio), 115409, Moscow, Russia.
- Department of Chemistry and Institute for Lasers, Photonics, and Biophotonics, University at Buffalo, The State University of New York, Buffalo, New York, 14260, United States.
| | - I N Zavestovskaya
- MEPhI, Institute of Engineering Physics for Biomedicine (PhysBio), 115409, Moscow, Russia
| | - A V Kabashin
- MEPhI, Institute of Engineering Physics for Biomedicine (PhysBio), 115409, Moscow, Russia.
- Aix Marseille Univ, CNRS, LP3, Campus de Luminy - Case 917, 13288, Marseille, France.
| |
Collapse
|